Viatris
Search results
Following the global transaction, Mylan Laboratories Limited and Mylan Pharmaceuticals Private Limited, the legal entities operating in India, became subsidiaries of Viatris Inc.
Mylan is now part of Viatris, a new global healthcare company committed to empowering people to live healthier at every stage of life. We encourage you to learn more about our commitment to increasing access to quality medicines for patients when and where they need them. Explore Viatris.
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. [2] Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK [3] and a "Global Center" in Canonsburg ...
Mylan Laboratories Limited is a Public incorporated on 29 November 1984. It is classified as Non-government company and is registered at Registrar of Companies, ROC Hyderabad. Its authorized share capital is Rs. 1,250,000,000 and its paid up capital is Rs. 487,025,270.
Mylan | 468,152 followers on LinkedIn. Follow us on our new journey as Viatris. www.linkedin.com/company/viatris | We have combined with Upjohn, a legacy division of Pfizer, and are now Viatris.
In 1972, Milan changed its name to Mylan Laboratories as a way to highlight its technical expertise and to make it easier for investors to find the company at the end of the fine-print stock listings in newspapers after the first shares of Mylan stock began trading under the ticker symbol MYLN.
